Rhumbline Advisers Applied Therapeutics Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 133,895 shares of APLT stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,895
Previous 544
24513.05%
Holding current value
$1.1 Million
Previous $3,000
20733.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
103MCall Options Held
797KPut Options Held
80.8K-
Franklin Resources Inc San Mateo, CA10.2MShares$83.5 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.54MShares$78.1 Million4.89% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$65.5 Million1.08% of portfolio
-
Janus Henderson Group PLC London, X07.65MShares$62.6 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$53.7 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $393M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...